000			05316cam a2200637 a 4500
001			on1159162541
003			OCoLC
005			20230516165856.0
006			m o d
007			cr un|---aucuu
008			200620s2020 ne o 001 0 eng d
040			_aEBLCP _beng _epn _cEBLCP _dYDX _dOPELS _dUKAHL _dOCLCF _dUKMGB _dN$T _dOCLCQ _dOCLCO _dK6U _dOCLCQ
015			_aGBC075827 _2bnb
016	7		_a019819556 _2Uk
019			_a1159206835
020			_a0081029861
020			_a9780081029862 _q(electronic bk.)
020			_z9780081029855
020			_z0081029853
035			_a(OCoLC)1159162541 _z(OCoLC)1159206835
050		4	_aR857.M3
082	0	4	_a610.28 _223
245	0	0	_aNanoengineered biomaterials for advanced drug delivery / _cedited by Masoud Mozafari.
260			_aAmsterdam : _bElsevier, _c2020.
300			_a1 online resource (826 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aWoodhead Publishing Series in Biomaterials
588	0		_aPrint version record.
505	0		_aIntro -- Nanoengineered Biomaterials for Advanced Drug Delivery -- Copyright -- Contents -- Contributors -- Preface -- Acknowledgment -- Part One Principles of nanotechnology-based drug delivery -- 1 Principles of nanosized drug delivery systems -- 1.1 Introduction -- 1.2 What are nanosized drug delivery systems and why they are useful? -- 1.3 Different types of nanodelivery systems -- 1.3.1 Polymeric nanoparticles -- 1.3.2 Liposomes -- 1.3.3 Niosomes -- 1.3.4 Solid lipid nanoparticles -- 1.3.5 Micro- and nanoemulsions -- 1.3.6 Polymeric micelles -- 1.3.7 Dendrimers
505	8		_a1.3.8 Inorganic nanoparticles and quantum dots -- 1.3.9 Nanocrystals -- 1.3.10 Protein-based and natural biopolymer-based nanoparticles -- 1.4 Particle properties and related biobarrier interactions of nanosystems -- 1.4.1 Opsonization and phagocytosis -- 1.4.2 Particle size -- 1.4.3 Shape -- 1.4.4 Surface charge -- 1.4.5 Hydrophilic/hydrophobic character -- 1.4.6 Other factors -- 1.5 Nanoparticles in medicines -- 1.5.1 Lipid nanotechnology -- 1.5.2 Nanoparticle nanotechnology -- 1.6 Conclusions -- References -- 2 Controlled/localized release and nanotechnology -- 2.1 Introduction
505	8		_a2.2 The evolution of drug delivery systems -- 2.3 Nanostructures from dimension viewpoint -- 2.3.1 Zero-dimensional nanostructures -- 2.3.2 One-dimensional nanostructures -- 2.3.3 Two-dimensional nanostructures -- 2.3.4 Three-dimensional nanostructures -- 2.4 Bionanostructures -- 2.5 Micro- and nanomotors -- 2.6 Conclusion -- References -- 3 Stimuli-sensitive drug delivery systems -- 3.1 Introduction -- 3.2 pH-sensitive drug delivery systems -- 3.3 Redox-sensitive drug delivery systems -- 3.4 Thermosensitive drug delivery systems -- 3.5 Magnetically sensitive drug delivery systems
505	8		_a3.6 Ultrasound-sensitive drug delivery systems -- 3.7 Photosensitive drug delivery systems -- 3.8 Electrosensitive drug delivery systems -- 3.8.1 Intrinsically conducting polymers -- 3.8.2 Hydrogels -- 3.9 Enzyme-sensitive drug delivery systems -- 3.10 Dual- and multisensitive drug delivery systems -- 3.11 Conclusions -- References -- 4 Sustainable drug delivery systems through green nanotechnology -- 4.1 Nanotechnology -- 4.2 Green nanotechnology -- 4.3 Green nanotechnology in drug delivery -- 4.4 Classification of nanoparticles -- 4.4.1 Liposomes -- 4.4.2 Polymeric nanoparticles
505	8		_a4.4.3 Dendrimer -- 4.4.4 Quantum dots -- 4.4.5 Silica nanoparticles -- 4.4.6 Magnetic nanoparticles -- 4.5 Metal-organic frameworks -- 4.6 Green methods for synthesis of MOFs -- 4.6.1 Mechanochemistry -- 4.6.2 Sonochemistry -- 4.6.3 Microwave -- 4.7 Synthesis of MOFs by using bioactive molecules -- 4.8 Summary -- References -- Further reading -- 5 Recent advances in multifunctional nanoengineered biomaterials -- 5.1 Introduction -- 5.2 Recent advances in imaging techniques -- 5.2.1 Optical imaging -- 5.2.2 Photoacoustic imaging -- 5.2.3 Multimodality imaging
500			_a5.3 Recent advances in biomedical applications
500			_aIncludes index.
650		0	_aNanostructured materials. _94537
650		0	_aBiomedical materials. _93868
650		0	_aDrug delivery systems. _97290
650		2	_aNanostructures _0(DNLM)D049329 _95928
650		2	_aBiocompatible Materials _0(DNLM)D001672 _95921
650		2	_aBiomedical and Dental Materials _0(DNLM)D001697 _968432
650		2	_aDrug Delivery Systems _0(DNLM)D016503 _97290
650		6	_aNanomat�eriaux. _0(CaQQLa)201-0258061 _968453
650		6	_aBiomat�eriaux. _0(CaQQLa)201-0025723 _968433
650		6	_aSyst�emes d'administration de m�edicaments. _0(CaQQLa)000260397 _968784
650		7	_aBiomedical materials. _2fast _0(OCoLC)fst00832586 _93868
650		7	_aDrug delivery systems. _2fast _0(OCoLC)fst00898667 _97290
650		7	_aNanostructured materials. _2fast _0(OCoLC)fst01032630 _94537
700	1		_aMozafari, Masoud. _968785
776	0	8	_iPrint version: _aMozafari, Masoud. _tNanoengineered Biomaterials for Advanced Drug Delivery. _dSan Diego : Elsevier, �2020
830		0	_aWoodhead Publishing series in biomaterials. _968481
856	4	0	_3ScienceDirect _uhttps://www.sciencedirect.com/science/book/9780081029855
942			_cEBK
999			_c82453 _d82453